PTK2B and prostate carcinoma: Several studies of PyK2 have verified that the over-expression and activation of PyK2 are related to cancer metastasis in numerous cancer cells, such as breast cancer, liver cancer, pancreatic cancer, prostate cancer, and glioma [19,58,72,73,74,75].